D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Other Equity Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Other Equity
myr1.2m
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
N/A
P
PeterLabs Holdings Bhd
KLSE:PLABS
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Other Equity
myr21m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
21%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Other Equity
-myr9k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kotra Industries Bhd
KLSE:KOTRA
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Duopharma Biotech Bhd's Other Equity?
Other Equity
1.2m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Other Equity amounts to 1.2m MYR.

What is Duopharma Biotech Bhd's Other Equity growth rate?
Other Equity CAGR 5Y
25%

Over the last year, the Other Equity growth was 306%. The average annual Other Equity growth rates for Duopharma Biotech Bhd have been 27% over the past three years , 25% over the past five years .

Back to Top